Literature DB >> 17454354

Targeted nanoparticle-based drug delivery and diagnosis.

Dwaine F Emerich1, Christopher G Thanos.   

Abstract

Nanotechnology, or systems/device manufacture at sizes generally ranging between 1 and 100 nm, is a multidisciplinary scientific field undergoing explosive development. The genesis of nanotechnology can be traced to advances in medicine, communications, genomics and robotics. One of the greatest values of nanotechnology will be in the development of new and effective medical treatments (i.e. nanomedicine). This review focuses on the potential of nanomedicine as it relates to the development of nanoparticles for enabling and improving the targeted delivery of therapeutic and diagnostic agents. We highlight the use of nanoparticles for specific intra-compartmental analysis using the examples of delivery to malignant cancers, to the central nervous system, and across the gastrointestinal barriers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17454354     DOI: 10.1080/10611860701231810

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  31 in total

1.  HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.

Authors:  Sarita Rani; Avinash Gothwal; Pawan K Pandey; Devendra S Chauhan; Praveen K Pachouri; Umesh D Gupta; Umesh Gupta
Journal:  Pharm Res       Date:  2018-12-03       Impact factor: 4.200

2.  Nanoparticle design optimization for enhanced targeting: Monte Carlo simulations.

Authors:  Shihu Wang; Elena E Dormidontova
Journal:  Biomacromolecules       Date:  2010-07-12       Impact factor: 6.988

3.  Nanoporous peptide particles for encapsulating and releasing neurotrophic factors in an animal model of neurodegeneration.

Authors:  Justin Tan; Yajun Wang; Xiaopei Yip; Fergal Glynn; Robert K Shepherd; Frank Caruso
Journal:  Adv Mater       Date:  2012-05-21       Impact factor: 30.849

Review 4.  Enabling individualized therapy through nanotechnology.

Authors:  Jason H Sakamoto; Anne L van de Ven; Biana Godin; Elvin Blanco; Rita E Serda; Alessandro Grattoni; Arturas Ziemys; Ali Bouamrani; Tony Hu; Shivakumar I Ranganathan; Enrica De Rosa; Jonathan O Martinez; Christine A Smid; Rachel M Buchanan; Sei-Young Lee; Srimeenakshi Srinivasan; Matthew Landry; Anne Meyn; Ennio Tasciotti; Xuewu Liu; Paolo Decuzzi; Mauro Ferrari
Journal:  Pharmacol Res       Date:  2010-01-05       Impact factor: 7.658

Review 5.  Applications of nanomaterials as vaccine adjuvants.

Authors:  Motao Zhu; Rongfu Wang; Guangjun Nie
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

Review 6.  Nanoparticles containing insoluble drug for cancer therapy.

Authors:  Shutao Guo; Leaf Huang
Journal:  Biotechnol Adv       Date:  2013-10-08       Impact factor: 14.227

Review 7.  Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.

Authors:  Omid Veiseh; Jonathan W Gunn; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

Review 8.  Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Authors:  Frank Alexis; Eric Pridgen; Linda K Molnar; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2008-08-04       Impact factor: 4.939

9.  Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth.

Authors:  Murali M Yallapu; Diane M Maher; Vasudha Sundram; Maria C Bell; Meena Jaggi; Subhash C Chauhan
Journal:  J Ovarian Res       Date:  2010-04-29       Impact factor: 4.234

Review 10.  Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy.

Authors:  Pedro P G Guimarães; Stephanie Gaglione; Tomasz Sewastianik; Ruben D Carrasco; Robert Langer; Michael J Mitchell
Journal:  ACS Nano       Date:  2018-02-06       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.